Table 3.
DBS level observed at visit “t–1” | DBS level observed at visit “t” | Total | ||
---|---|---|---|---|
Low | Moderate | High | ||
Low | 86 (83.5%) | 9 (8.7%) | 8 (7.8%) | 103 |
Moderate | 20 (31.7%) | 22 (34.9%) | 21 (33.3%) | 63 |
High | 17 (6.4%) | 32 (12.0%) | 218 (81.6%) | 267 |
Note: Low level: <350 fmol/punch, moderate: 350–699 fmol/punch and high: ≥700 fmol/punch. Table 3 shows the absolute and relative frequencies of DBS measure transitions from one visit to the following. These percentages estimate the transition probabilities Pr (Yit | Yit − 1) based on the correlation between PrEP adherence by DBS of each participant by visit pairs (i.e. a specific visit and its following visit). There are 433 transitions (or “pairs”) between the 563 observations since there is no participant's status before the first visit. Among participants with a low DSB level in the visit “t–1,” 83.5% maintained a low DBS level in the following visit (“t”). Among participants with a high DBS level in the visit “t–1,” 81.6% maintained a high DBS level in the next visit (“t”).
Abbreviations: DBS, dried blood spots; TGW, transgender women.